The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,011,016 in first-year total cost, median $929,754.
Most frequent study sections
- Special Emphasis Panel[ZMH1 ERB-G (03)]3
Most frequent institutions
- OREGON HEALTH & SCIENCE UNIVERSITY1
- TEXAS BIOMEDICAL RESEARCH INSTITUTE1
- UNIVERSITY OF MINNESOTA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence1R01MH130197-01 | NDHLOVU, LISHOMWA COKOYE, AFAMEFUNATRAUTMANN, LYDIE | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $1,165,864 | ZMH1 |
| 2022 | Targeting CNS reservoirs with CAR/CXCR5 T cells for the long-term remission of HIV1R01MH130177-01 | BYRAREDDY, SIDDAPPA NNDHLOVU, LISHOMWA CRAKASZ, EVA GIZELLASKINNER, PAMELA J | UNIVERSITY OF MINNESOTA, MN | $929,754 | ZMH1 |
| 2022 | Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication1R01MH130193-01 | HU, WENHUILING, BINHUA "JULIE" | TEXAS BIOMEDICAL RESEARCH INSTITUTE, TX | $915,398 | ZMH1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.1.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.